# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Vivakor (NASDAQ:VIVK) reported quarterly losses of $(0.18) per share. This is a 76.32 percent increase over losses of $(0.76) p...
Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase...